ZBH Zimmer Biomet Holdings, Inc. Common Stock
$100,01
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 5, 2026
52W-Spanne
$79–$108
72% of range
Analystenbewertung
HOLD
33 analysts
Kursziel
$108
+8% upside
P/E (TTM)
28.2
ROE
5.6%
Nettogewinnmarge
8.6%
Über Zimmer Biomet Holdings, Inc. Common Stock Unternehmensübersicht von Wikipedia
Zimmer Biomet Holdings, Inc. ist ein US-amerikanisches Medizintechnik-Unternehmen, das weltweit zu den größten Anbietern von orthopädischen Implantaten gehört. Der Hauptsitz des Unternehmens befindet sich in Warsaw, Bundesstaat Indiana. Das Unternehmen ist im S&P 500 gelistet.
Mehr lesen
Zimmer Biomet Holdings, Inc. (NYSE: ZBH) ist ein US-amerikanisches Medizintechnik-Unternehmen, das weltweit zu den größten Anbietern von orthopädischen Implantaten gehört. Der Hauptsitz des Unternehmens befindet sich in Warsaw, Bundesstaat Indiana. Das Unternehmen ist im S&P 500 gelistet.
Die Zentrale für die EMEA-Region befindet sich in Zug in der Schweiz und ging aus Centerpulse, einem Spinoff von Sulzer Medica, hervor. Der Sitz des deutschen Zweiges ist in Eschbach im Breisgau.
Im britischen Englisch hat sich die Bezeichnung zimmer frame, kurz zimmer, als Gattungsname für die Gehhilfe Rollator verbreitet.
Produkte
Zu den Hauptprodukten gehören Knie-, Hüft-, Schulter-, Ellbogen-, Wirbelsäulen- und Zahnimplantate sowie Platten und Schrauben zur Knochenbruchbehandlung. Seit 2006 bietet Zimmer ein Knieimplantat an, das speziell für die weibliche Anatomie konzipiert wurde.
2016 verkaufte das Unternehmen Knieprodukte im Wert von 2,752 Mrd. US-Dollar, Hüftprodukte von 1,868 Mrd. USD, 662 Mio. USD im CMF&Wirbelsäulen-Bereich, Zahnprodukte für 428 Mio. USD und 1,645 Mrd. USD im S.E.T-Bereich des Unternehmens, welches Chirurgie, Sportmedizin, Fuß, Knöchel, Extremitäten und Traumata umfassen. Dazu kamen noch diverse Umsätze von 329 Mio. USD, die nicht einem spezifischen Bereich zugeordnet wurden. Gegenüber dem Jahr 2015 konnte Zimmer Biomet seinen Umsatz um 28,1 % steigern.
Geschichte
Zimmer Holdings wurde 1927 von Justin O. Zimmer (1884–1951) gegründet und erwirtschaftete mit der Produktion von Aluminiumschienen im ersten Jahr bereits einen Umsatz von $160.000. 1933 wurde eine Abteilung für Verbände gegründet. 1942 durchbricht der Umsatz der Firma die Millionenmarke.
1950 bringt Zimmer die erste von Palmer Eicher entwickelte Hüftprothese auf den Markt, 1951 erreicht Zimmer erstmals einen Umsatz von 2 Millionen US-Dollar, 1960 sind es bereits doppelt so viel. 1967 baut das Unternehmen eine eigene Exportabteilung auf, ein Jahr später kauft Zimmer großflächig Land für die Erweiterung ihrer Produktionsstätten. 1979 wird die auf Weichwaren spezialisierte Little Manufacturing Company in North Carolina übernommen. Zur kommenden Jahrzehntwende beschäftigte Zimmer dann 522 Mitarbeiter, die einen Umsatz von 27,2 Mio. US-Dollar. Ab 1971 vertrieb Zimmer die Charnley Hüft-Prothese.
Das Unternehmen wurde 1972 von Bristol-Myers Squibb erworben und sie stellen am Jahrestreffen der AAOS die ersten Polyethylenprothesen vor. 1977 wird in Japan das Marketingunternehmen Nemoto Shokai übernommen und damit der Grundstein für Zimmer Japan gelegt. 1987 macht das Unternehmen bereits einen Umsatz von 500 Millionen US-Dollar, 1992 erfolgt der Bezug eines neuen Hauptsitzes in Warsaw (Indiana). 1993 wird eine weitere Produktionsstätte in puerto-ricanischen Ponce eröffnet.
2001 wurde Zimmer Holdings von Bristol-Myers Squibb abgetrennt und erneut unabhängig. Am 7. August 2001 erfolgte der Börsengang an der New York Stock Exchange. 2003 erwarb Zimmer das Schweizer Unternehmen Centerpulse AG, die ehemalige Medizintechniksparte des Sulzer-Konzerns. Centerpulse war der bedeutendste Hersteller von Orthopädie-Implantaten in Europa. Ebenfalls seit 2003 bietet das Zimmer Institute Orthopäden Kurse in verschiedenen Operationstechniken an.
Am 24. April 2014 kündigte Zimmer Holdings an, das Medizintechnik-Unternehmen Biomet Inc. für 13,4 Mrd. US-Dollar übernehmen zu wollen. Im Juni 2015 wurde der Kauf von Biomet abgeschlossen und der Firmenname in Zimmer Biomet Holdings geändert.
2021 ging Zimmer Holdings eine Partnerschaft mit dem Medizintechnikunternehmen OSSIS ein. 2023 erwarb Zimmer Holdings OSSIS.
Ein internationaler Rechercheverbund nannte im November 2018 das vom Markt genommene künstliche Hüftgelenk Durom-Metasul-LDH als Beispiel für mangelhafte medizinische Implantate; rund 100 Geschädigte warten auf eine Entscheidung des Landgericht Freiburg. Durch eine Fehlkonstruktion soll sich Metall abgerieben haben. Dieses Metall habe sich im Körper verteilt und zu Knochenabbau geführt.
Kritik
Während der Russischen Invasion in der Ukraine 2022 setzte Zimmer Biomet weiterhin den Verkauf auf dem russischen Markt fort. Eine Untersuchung von Yale University, die am 28. April 2022 aktualisiert wurde und analysierte, wie Unternehmen auf die russische Invasion reagierten, identifizierte Zimmer Biomet als ein Unternehmen, das weiterhin „business-as-usual“ in Russland betrieb: Unternehmen, die den Aufforderungen zur Beendigung bzw. Reduzierung ihrer Aktivitäten nicht nachkamen.
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
ZBH Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$100.00
Marktkapitalisierung
$31.93B
P/E (TTM)
28.2
EPS (TTM)
$3.55
Umsatz (TTM)
$8.23B
Dividendenrendite
0.59%
ROE
5.6%
Verschuldungsgrad
0.6
52W-Spanne
$79 – $108
ZBH Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$8.23B
2016-12-31
→
2025-12-31
EPS
$3.55
2016-12-31
→
2025-12-31
Freier Cashflow
$1.47B
2016-12-31
→
2025-12-31
Margen
8.6%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
ZBH
Peer-Median
P/E (TTM)
28.2
27.5
P/S (TTM) (K/V (TTM))
3.9
3.7
P/B (K/B)
2.5
3.4
EV / EBITDA
17.7
—
Price / FCF (Kurs / FCF)
21.7
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
ZBH
Peer-Median
Operating Margin (Betriebsgewinnmarge)
13.3%
—
Net Profit Margin (Nettogewinnmarge)
8.6%
9.8%
ROA
3.2%
5.1%
ROE
5.6%
8.6%
ROIC
4.6%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
ZBH
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
0.6
—
Current Ratio (Liquiditätsgrad)
2.0
2.7
Quick Ratio
0.9
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
ZBH
Peer-Median
Revenue YoY (Umsatz YoY)
7.2%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
5.9%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
6.1%
—
EPS YoY (EPS VjV)
-19.9%
—
Net Income YoY (Nettogewinn YoY)
-22.0%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
ZBH
Peer-Median
Payout Ratio (Ausschüttungsquote)
27.0%
—
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
Dividendenrendite
0.59%
Ausschüttungsquote
27.0%
5J Div CAGR
—
| Ex-Datum | Betrag |
|---|---|
| 25. Juni 2026 | $0,2400 |
| 31. März 2026 | $0,2400 |
| 30. Dezember 2025 | $0,2400 |
| 30. September 2025 | $0,2400 |
| 26. Juni 2025 | $0,2400 |
| 31. März 2025 | $0,2400 |
| 30. Dezember 2024 | $0,2400 |
| 30. September 2024 | $0,2400 |
| 26. Juni 2024 | $0,2400 |
| 27. März 2024 | $0,2400 |
| 26. Dezember 2023 | $0,2400 |
| 28. September 2023 | $0,2400 |
| 23. Juni 2023 | $0,2400 |
| 28. März 2023 | $0,2400 |
| 23. Dezember 2022 | $0,2400 |
| 29. September 2022 | $0,2400 |
| 24. Juni 2022 | $0,2400 |
| 28. März 2022 | $0,2400 |
| 27. Dezember 2021 | $0,2330 |
| 29. September 2021 | $0,2330 |
ZBH Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
HALTEN
33 Analysten
- Starker Kauf 3 9,1%
- Kauf 8 24,2%
- Halten 22 66,7%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
21 Analysten · 2026-08-18
Median
$106.00
Jetzt
$100.00
Tief
$93.00
Hoch
$130.00
Median-Ziel
$106.00
+6,0%
Mittelwert-Ziel
$107.57
+7,6%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.06%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $2.07 | $2.03 | 0.04% |
| 31. März 2026 | $2.09 | $1.88 | 0.21% |
| 31. Dezember 2025 | $2.42 | $2.42 | 0.00% |
| 30. September 2025 | $1.90 | $1.89 | 0.01% |
| 30. Juni 2025 | $2.07 | $2.00 | 0.07% |
| 31. März 2025 | $1.81 | $1.79 | 0.02% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | — |
| BDX | — | 25.3 | 8.2% | 7.7% | 6.5% | — |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| GEHC | — | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
| GMED | — | 22.3 | 16.7% | 18.3% | 12.1% | — |
| GKOS | $6.49B | -34.4 | 32.3% | -37.0% | -26.4% | 55.7% |
| PODD | $20.01B | 81.7 | 30.7% | 9.1% | 16.6% | 71.6% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.23B | $7.68B | $7.39B | $6.94B | $6.83B | $6.13B | $7.98B | $7.93B | $7.80B | $7.67B | $6.00B | $4.67B | |
| Cost of Revenue | $2.49B | $2.19B | $2.08B | $2.02B | $1.96B | $1.82B | $2.25B | $2.27B | $2.13B | $2.38B | $1.80B | $1.24B | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | · | $3.42B | |
| SG&A Expense | $3.26B | $2.93B | $2.84B | $2.76B | $2.84B | $2.71B | $3.34B | $3.38B | $3.10B | $2.94B | $2.28B | $1.75B | |
| Operating Expenses | $7.13B | $6.39B | $6.12B | $6.24B | $5.97B | $6.04B | $6.84B | $7.90B | $7.00B | $6.85B | $5.53B | $3.64B | |
| Operating Income | $1.10B | $1.29B | $1.28B | $696M | $860M | $83M | $1.14B | $34M | $799M | $821M | $467M | $1.04B | |
| Interest Income | · | · | · | · | · | · | · | · | $2M | $3M | $9M | $12M | |
| Other Non-op | $26M | $-31M | $-9M | $-128M | $12M | $24M | $-5M | $-16M | $-9M | $-66M | $-37M | $-47M | |
| Pretax Income | $831M | $1.04B | $1.07B | $404M | $499M | $-105M | $906M | $-271M | $465M | $400M | $153M | $939M | |
| Income Tax | $126M | $131M | $42M | $112M | $54M | $-96M | $-226M | $108M | $-1.35B | $95M | $7M | $220M | |
| Net Income | $705M | $904M | $1.02B | $231M | $402M | $-139M | $1.13B | $-379M | $1.81B | $306M | $147M | $720M | |
| EPS (Basic) | $3.56 | $4.45 | $4.91 | $1.10 | $1.93 | $-0.67 | $5.52 | $-1.86 | $8.98 | $1.53 | $0.78 | $4.26 | |
| EPS (Diluted) | $3.55 | $4.43 | $4.88 | $1.10 | $1.91 | $-0.67 | $5.47 | $-1.86 | $8.90 | $1.51 | $0.77 | $4.20 | |
| Shares (Basic) | 198,000,000 | 203,100,000 | 208,700,000 | 209,600,000 | 208,600,000 | 207,000,000 | 205,100,000 | 203,500,000 | 201,900,000 | 200,000,000 | 187,400,000 | 169,000,000 | |
| Shares (Diluted) | 198,700,000 | 203,900,000 | 209,700,000 | 210,300,000 | 210,400,000 | 207,000,000 | 206,700,000 | 203,500,000 | 203,700,000 | 202,400,000 | 189,800,000 | 171,700,000 | |
| EBITDA | $2.19B | $2.28B | $2.23B | $1.62B | $1.85B | $945M | $2.14B | $1.07B | $1.87B | $1.87B | $1.18B | $1.41B |
Bilanz 28
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $592M | $526M | $416M | $376M | $378M | $802M | $618M | $543M | $524M | $634M | $1.46B | $1.08B | |
| Receivables | $1.70B | $1.48B | $1.44B | $1.38B | $1.26B | $1.45B | $1.36B | $1.28B | $1.54B | $1.60B | $1.45B | $912M | |
| Inventory | $2.29B | $2.24B | $2.39B | $2.15B | $2.15B | $2.45B | $2.38B | $2.26B | $2.07B | $1.96B | $2.25B | $1.19B | |
| Prepaid Expense | $537M | $430M | $366M | $523M | $271M | $169M | $357M | $352M | $428M | $466M | $529M | $317M | |
| Current Assets | $5.12B | $4.67B | $4.61B | $4.43B | $4.88B | $5.08B | $4.72B | $4.43B | $4.56B | $4.66B | $5.85B | $4.31B | |
| PP&E (Net) | $2.21B | $2.05B | $2.06B | $1.87B | $1.84B | $2.05B | $2.08B | $2.02B | $2.04B | $2.04B | $2.06B | $1.29B | |
| PP&E (Gross) | $7.26B | $6.69B | $6.77B | $6.46B | $6.14B | $6.32B | $5.92B | $5.44B | $5.08B | $4.67B | $4.43B | $3.41B | |
| Accum. Depreciation | $5.05B | $4.64B | $4.71B | $4.59B | $4.30B | $4.28B | $3.84B | $3.42B | $3.05B | $2.63B | $2.37B | $2.12B | |
| Goodwill | $9.95B | $8.95B | $8.82B | $8.58B | $8.92B | $8.98B | $9.60B | $9.59B | $10.67B | $10.64B | $9.93B | $2.51B | |
| Intangibles | $4.72B | $4.60B | $4.86B | $5.06B | $5.53B | $7.06B | $7.26B | $7.68B | $8.35B | $8.79B | $8.75B | $604M | |
| Other Non-current Assets | $1.10B | $1.10B | $1.15B | $1.12B | $1.00B | $969M | $980M | $405M | $389M | $554M | $564M | $942M | |
| Total Assets | $23.09B | $21.37B | $21.50B | $21.07B | $23.46B | $24.42B | $24.64B | $24.13B | $26.01B | $26.68B | $27.16B | $9.66B | |
| Accounts Payable | $303M | $195M | $411M | $354M | $306M | $330M | $401M | $363M | $330M | $364M | $285M | $145M | |
| Accrued Liabilities | $834M | $706M | $804M | $582M | $536M | $873M | $778M | $671M | $775M | $789M | $726M | $351M | |
| Current Liabilities | $2.58B | $2.45B | $2.86B | $2.36B | $3.47B | $2.56B | $3.44B | $2.42B | $3.07B | $2.38B | $1.62B | $1.02B | |
| Capital Leases | $176M | $190M | $174M | $167M | $175M | $218M | $216M | · | · | · | · | · | |
| Deferred Tax | $244M | $352M | $358M | $475M | $558M | $790M | $840M | $1000M | $1.10B | $3.03B | $3.15B | $46M | |
| Other Non-current Liabilities | $626M | $744M | $926M | $633M | $548M | $656M | $558M | $350M | $446M | $463M | $1.01B | $611M | |
| Total Liabilities | $10.39B | $8.89B | $9.01B | $9.04B | $10.79B | $12.22B | $12.25B | $12.85B | $14.28B | $17.01B | $17.27B | $3.11B | |
| Long-term Debt | $7.52B | $6.20B | $5.77B | $5.70B | $1.00B | $8.13B | $8.22B | $8.94B | $10.14B | $11.24B | · | · | |
| Total Debt | $7.52B | $6.20B | $5.77B | $5.70B | $7.07B | $8.13B | $8.22B | $8.94B | $10.14B | $11.24B | $11.56B | $1.43B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Retained Earnings | $11.61B | $11.10B | $10.38B | $9.56B | $10.29B | $10.09B | $10.43B | $9.49B | $10.02B | $8.47B | $8.35B | $8.36B | |
| Treasury Stock | $8.89B | $8.41B | $7.56B | $6.87B | $6.72B | $6.72B | $6.72B | $6.72B | $6.72B | $6.74B | $6.33B | $6.18B | |
| AOCI | $-206M | $-263M | $-191M | $-179M | $-232M | $-298M | $-242M | $-187M | $-83M | $-434M | $-329M | $38M | |
| Stockholders' Equity | $12.70B | $12.47B | $12.48B | $12.02B | $12.66B | $12.19B | $12.39B | $11.27B | $11.74B | $9.67B | $9.89B | $6.55B | |
| Liabilities + Equity | $23.09B | $21.37B | $21.50B | $21.07B | $23.46B | $24.42B | $24.64B | $24.13B | $26.01B | $26.68B | $27.16B | $9.66B | |
| Shares Outstanding | 318,700,000 | 317,500,000 | 316,200,000 | 313,800,000 | 312,800,000 | 311,400,000 | 309,900,000 | 307,900,000 | 306,500,000 | 304,700,000 | 302,700,000 | 268,400,000 |
Cashflow 18
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.09B | $996M | $952M | $926M | $938M | $898M | $1.01B | $1.04B | $1.06B | $1.04B | $712M | $376M | |
| Stock-based Comp | $90M | $101M | $100M | $105M | $76M | $74M | $84M | $66M | $54M | $57M | $46M | $49M | |
| Deferred Tax | $-87M | $-48M | $-96M | $-64M | $-102M | $39M | $-539M | $13M | $-1.78B | $-153M | $-164M | $-90M | |
| Amort. of Intangibles | $666M | $592M | $562M | $527M | $530M | $512M | $584M | $596M | $604M | $566M | $337M | $92M | |
| Restructuring | · | · | · | · | $32M | · | · | · | $17M | $91M | $196M | · | |
| Other Non-cash | $-105M | $-454M | $-398M | $158M | $95M | $219M | $-98M | $1.01B | $428M | $383M | $75M | $-8M | |
| Operating Cash Flow | $1.70B | $1.50B | $1.58B | $1.36B | $1.40B | $1.08B | $1.59B | $1.75B | $1.58B | $1.63B | $850M | $1.06B | |
| CapEx | $224M | $204M | $291M | $188M | $144M | $112M | $207M | $163M | $156M | $185M | $168M | $145M | |
| Investing Cash Flow | $-1.98B | $-888M | $-779M | · | $-504M | $-614M | $-729M | $-417M | $-511M | $-1.69B | · | · | |
| Debt Issued | · | · | · | · | · | · | · | · | · | $750M | $3.00B | · | |
| Net Debt Issued | · | · | · | · | · | · | · | $-1.43B | $-940M | $-50M | $2.50B | · | |
| Stock Repurchased | $487M | $868M | $692M | $126M | · | · | · | · | · | $416M | $150M | $401M | |
| Net Stock Activity | $-487M | $-868M | $-692M | $-126M | · | · | · | · | · | $-416M | $-150M | $-400M | |
| Dividends Paid | $190M | $196M | $201M | $201M | $200M | $198M | $197M | $195M | $194M | $188M | $157M | $146M | |
| Financing Cash Flow | $326M | $-484M | $-764M | · | $-1.31B | $-422M | $-780M | $-1.30B | $-1.21B | $-743M | · | · | |
| Net Change in Cash | $66M | $110M | $40M | $-103M | $-324M | $184M | $75M | $18M | $-110M | $-825M | $376M | $3M | |
| Taxes Paid | $377M | $328M | $215M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.47B | $1.30B | $1.29B | $1.17B | $1.33B | $1.09B | $1.38B | $1.58B | $1.43B | $1.45B | $649M | $908M |
Rentabilität 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | · | · | · | 73.3% | |
| Operating Margin | 13.3% | 16.7% | 17.3% | 10.0% | 10.0% | -1.2% | 14.2% | 0.43% | 10.3% | 10.8% | 7.8% | 22.1% | |
| Net Margin | 8.6% | 11.8% | 13.9% | 3.3% | 5.1% | -2.0% | 14.2% | -4.8% | 23.2% | 4.0% | 2.5% | 15.4% | |
| Pretax Margin | 10.1% | 13.5% | 14.4% | 5.8% | 5.3% | -3.9% | 11.3% | -3.4% | 5.9% | 5.2% | 2.5% | 20.2% | |
| EBITDA Margin | 26.6% | 29.7% | 30.1% | 23.4% | 23.6% | 13.5% | 26.9% | 13.5% | 23.9% | 24.3% | 19.7% | 30.2% | |
| ROA | 3.2% | 4.2% | 4.8% | 1.0% | 1.7% | -0.57% | 4.6% | -1.5% | 6.9% | 1.1% | 0.54% | 7.5% | |
| ROE | 5.6% | 7.2% | 8.4% | 1.9% | 3.2% | -1.1% | 9.6% | -3.3% | 17.0% | 3.1% | 1.5% | 11.2% | |
| ROIC | 4.6% | 6.0% | 6.7% | 2.8% | 3.8% | -0.22% | 6.9% | 0.23% | 14.4% | 3.0% | 2.1% | 9.9% |
Liquidität & Solvenz 4
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 1.9 | 1.6 | 1.9 | 1.4 | 2.0 | 1.4 | 1.8 | 1.5 | 2.0 | 3.6 | 4.1 | |
| Quick Ratio | 0.9 | 0.8 | 0.7 | 0.7 | 0.5 | 0.9 | 0.6 | 0.8 | 0.7 | 0.9 | 1.8 | 1.9 | |
| Debt / Equity | 0.6 | 0.5 | 0.5 | 0.5 | 0.6 | 0.7 | 0.7 | 0.8 | 0.9 | 1.2 | 1.2 | 0.2 | |
| LT Debt / Equity | 0.5 | 0.4 | 0.4 | 0.4 | 0.4 | 0.6 | 0.5 | 0.7 | 0.8 | 1.1 | 1.2 | 0.2 |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.5 | |
| Inventory Turnover | 1.1 | 0.9 | 0.9 | 0.9 | 1.0 | 0.9 | 1.0 | 1.1 | 1.1 | 1.1 | 0.8 | 1.1 | |
| Receivables Turnover | 5.2 | 5.3 | 5.2 | 5.3 | 5.5 | 5.0 | 6.0 | 5.6 | 5.0 | 5.0 | 5.1 | 5.1 |
Wachstumsraten 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.2% | 3.9% | 6.6% | 1.7% | 11.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.9% | 4.0% | 6.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 6.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -19.9% | -9.2% | 343.6% | -42.4% | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 47.8% | 32.4% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -22.0% | -11.7% | 342.5% | -42.4% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 45.0% | 31.1% | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | -0.84% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8.23B | $7.68B | $7.39B | $6.94B | $6.83B | $6.13B | $7.98B | $7.93B | $7.80B | $7.67B | $6.00B | $4.67B | |
| Net Income TTM | $705M | $904M | $1.02B | $231M | $402M | $-139M | $1.13B | $-379M | $1.81B | $306M | $147M | $720M | |
| Market Cap | $28.66B | $33.54B | $38.48B | $40.01B | $38.58B | $46.59B | $45.03B | $31.01B | $35.91B | $30.53B | $30.15B | · | |
| Enterprise Value | $35.58B | $39.22B | $43.83B | $45.33B | $45.17B | $53.91B | $52.64B | $39.40B | $45.53B | $41.14B | $40.25B | · | |
| P/E | 25.3 | 23.8 | 24.9 | 115.9 | 64.6 | -223.3 | 26.6 | -54.1 | 13.2 | 66.4 | 129.4 | 26.2 | |
| P/S | 3.5 | 4.4 | 5.2 | 5.8 | 5.7 | 7.6 | 5.6 | 3.9 | 4.6 | 4.0 | 5.0 | · | |
| P/B | 2.3 | 2.7 | 3.1 | 3.3 | 3.0 | 3.8 | 3.6 | 2.8 | 3.1 | 3.2 | 3.0 | · | |
| P / Cash Flow | 16.9 | 22.4 | 24.3 | 29.5 | 25.7 | 38.7 | 28.4 | 17.7 | 22.7 | 18.7 | 36.9 | · | |
| P / FCF | 19.5 | 25.9 | 29.8 | 34.2 | 29.1 | 42.9 | 32.7 | 19.6 | 25.2 | 21.1 | 46.5 | · | |
| EV / EBITDA | 16.2 | 17.2 | 19.7 | 27.9 | 24.4 | 57.1 | 24.6 | 36.7 | 24.3 | 22.1 | 34.1 | · | |
| EV / FCF | 24.2 | 30.3 | 34.0 | 38.8 | 34.0 | 49.6 | 38.2 | 24.9 | 31.9 | 28.4 | 62.0 | · | |
| EV / Revenue | 4.3 | 5.1 | 5.9 | 6.5 | 6.6 | 8.8 | 6.6 | 5.0 | 5.8 | 5.4 | 6.7 | · | |
| Dividend Yield | 0.66% | 0.58% | 0.52% | 0.50% | 0.52% | 0.43% | 0.44% | 0.63% | 0.54% | 0.62% | 0.52% | · | |
| Earnings Yield | 4.0% | 4.2% | 4.0% | 0.86% | 1.6% | -0.45% | 3.8% | -1.8% | 7.6% | 1.5% | 0.77% | 3.8% | |
| Payout Ratio | 27.0% | 21.7% | 19.6% | 87.0% | 49.8% | -142.9% | 17.4% | -51.5% | 10.7% | 61.6% | 106.9% | 20.2% | |
| Annual Payout | $190M | $196M | $201M | $201M | $200M | $198M | $197M | $195M | $194M | $188M | $157M | $146M |
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.18B | $2.09B | $2.24B | $2.00B | $2.08B | $1.91B | $2.02B | $1.82B | $1.94B | $1.89B | $1.94B | $1.75B | $1.87B | $1.83B | $1.83B | $1.67B | |
| Cost of Revenue | $636M | $576M | $792M | $559M | $592M | $550M | $587M | $539M | $554M | $512M | $539M | $519M | $526M | $501M | $520M | $488M | |
| SG&A Expense | $899M | $850M | $872M | $811M | $815M | $759M | $747M | $710M | $737M | $736M | $722M | $675M | $726M | $716M | $727M | $655M | |
| Operating Expenses | $1.85B | $1.71B | $2.09B | $1.65B | $1.78B | $1.62B | $1.63B | $1.54B | $1.59B | $1.62B | $1.59B | $1.49B | $1.54B | $1.50B | $1.85B | $1.42B | |
| Operating Income | $326M | $373M | $154M | $351M | $300M | $292M | $389M | $280M | $351M | $266M | $354M | $267M | $330M | $327M | $-28M | $245M | |
| Other Non-op | $2M | $-3M | $15M | $3M | $4M | $3M | $-38M | $5M | $2M | $-100.0K | $-20M | $4M | $-1M | $8M | $-4M | $-25M | |
| Pretax Income | $255M | $301M | $98M | $279M | $225M | $229M | $289M | $230M | $302M | $215M | $284M | $219M | $277M | $287M | $-75M | $178M | |
| Income Tax | $56M | $63M | $-40M | $48M | $71M | $46M | $49M | $-19M | $59M | $42M | $-135M | $56M | $67M | $54M | $55M | $-17M | |
| Net Income | $198M | $238M | $139M | $231M | $153M | $182M | $240M | $249M | $243M | $172M | $419M | $163M | $210M | $232M | $-130M | $194M | |
| EPS (Basic) | $1.03 | $1.22 | $0.70 | $1.17 | $0.77 | $0.92 | $1.20 | $1.23 | $1.18 | $0.84 | $2.02 | $0.78 | $1.00 | $1.11 | $-0.62 | $0.92 | |
| EPS (Diluted) | $1.03 | $1.22 | $0.71 | $1.16 | $0.77 | $0.91 | $1.18 | $1.23 | $1.18 | $0.84 | $2.00 | $0.77 | $1.00 | $1.11 | $-0.62 | $0.92 | |
| Shares (Basic) | 192,200,000 | 195,000,000 | -396,900,000 | 198,100,000 | 197,900,000 | 198,900,000 | -410,100,000 | 202,300,000 | 205,700,000 | 205,200,000 | -418,200,000 | 208,900,000 | 208,600,000 | 209,400,000 | -419,000,000 | 209,800,000 | |
| Shares (Diluted) | 192,800,000 | 195,800,000 | -398,100,000 | 198,800,000 | 198,300,000 | 199,700,000 | -411,700,000 | 203,000,000 | 206,400,000 | 206,200,000 | -420,600,000 | 210,000,000 | 209,900,000 | 210,400,000 | -420,400,000 | 210,300,000 | |
| EBITDA | $326M | $643M | · | $351M | $300M | $547M | · | $280M | $351M | $504M | · | $267M | $330M | $559M | · | $245M |
Bilanz 28
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $410M | $424M | $592M | $1.29B | $557M | $1.38B | $526M | $569M | $420M | $393M | · | $292M | $320M | $330M | · | $545M | |
| Receivables | $1.77B | $1.73B | $1.70B | $1.60B | $1.61B | $1.53B | $1.48B | $1.48B | $1.42B | $1.45B | · | $1.34B | $1.37B | $1.38B | · | $1.28B | |
| Inventory | $2.27B | $2.25B | $2.29B | $2.48B | $2.45B | $2.24B | $2.24B | $2.37B | $2.37B | $2.39B | · | $2.32B | $2.28B | $2.24B | · | $2.13B | |
| Prepaid Expense | $647M | $563M | $537M | $460M | $431M | $428M | $430M | $445M | $431M | $404M | · | $416M | $425M | $460M | · | $347M | |
| Current Assets | $5.10B | $4.96B | $5.12B | $5.83B | $5.05B | $5.59B | $4.67B | $4.86B | $4.64B | $4.63B | · | $4.37B | $4.39B | $4.41B | · | $4.53B | |
| PP&E (Net) | $2.24B | $2.21B | $2.21B | $2.19B | $2.18B | $2.06B | $2.05B | $2.11B | $2.10B | $2.09B | · | $2.03B | $1.98B | $1.91B | · | $1.80B | |
| PP&E (Gross) | $7.42B | $7.30B | $7.26B | $7.22B | $7.15B | $6.82B | $6.69B | $6.90B | $6.74B | $6.85B | · | $6.65B | $6.72B | $6.59B | · | $6.34B | |
| Accum. Depreciation | $5.18B | $5.09B | $5.05B | $5.03B | $4.97B | $4.76B | $4.64B | $4.79B | $4.64B | $4.76B | · | $4.61B | $4.74B | $4.69B | · | $4.54B | |
| Goodwill | $9.92B | $9.93B | $9.95B | $9.70B | $9.71B | $8.99B | $8.95B | $8.91B | $8.82B | $8.79B | $8.82B | $8.71B | $8.74B | $8.73B | $8.58B | $8.80B | |
| Intangibles | $4.46B | $4.55B | $4.72B | $4.74B | $4.89B | $4.47B | $4.60B | $4.67B | $4.71B | $4.73B | · | $4.89B | $5.03B | $5.07B | · | $5.14B | |
| Other Non-current Assets | $1.08B | $1.07B | $1.10B | $1.02B | $1.04B | $1.07B | $1.10B | $1.17B | $1.25B | $1.20B | · | $1.21B | $1.16B | $1.12B | · | $1.06B | |
| Total Assets | $22.80B | $22.72B | $23.09B | $23.49B | $22.87B | $22.18B | $21.37B | $21.72B | $21.52B | $21.45B | · | $21.22B | $21.29B | $21.24B | · | $21.33B | |
| Accounts Payable | $352M | $361M | $303M | $315M | $349M | $301M | $195M | $322M | $342M | $370M | · | $320M | $355M | $397M | · | $334M | |
| Accrued Liabilities | · | · | $834M | · | · | · | $706M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $3.01B | $2.86B | $2.58B | $2.40B | $2.70B | $2.29B | $2.45B | $3.57B | $3.61B | $2.80B | · | $2.07B | $2.23B | $2.34B | · | $2.30B | |
| Capital Leases | · | · | $176M | · | · | · | $190M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $236M | $250M | $244M | · | · | · | $352M | · | · | $370M | · | $465M | $475M | $485M | · | $541M | |
| Other Non-current Liabilities | $639M | $631M | $626M | $806M | $879M | $909M | $744M | $1.03B | $1.21B | $577M | · | $632M | $642M | $637M | · | $609M | |
| Total Liabilities | $10.17B | $10.04B | $10.39B | $10.72B | $10.33B | $9.78B | $8.89B | $9.34B | $8.77B | $8.85B | · | $8.70B | $8.92B | $9.09B | · | $9.08B | |
| Long-term Debt | $7.48B | $7.47B | $7.52B | $8.11B | $7.57B | $7.18B | $6.20B | $6.45B | $5.83B | $5.80B | · | $5.48B | $5.71B | $5.79B | · | $5.71B | |
| Total Debt | $7.48B | $7.47B | · | $8.11B | $7.57B | $7.18B | · | $6.45B | $5.83B | $5.80B | · | $5.48B | $5.71B | $5.79B | · | $5.71B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Retained Earnings | $11.96B | $11.80B | $11.61B | $11.52B | $11.34B | $11.23B | $11.10B | $10.90B | $10.70B | $10.51B | · | $10.01B | $9.90B | $9.74B | · | $9.74B | |
| Treasury Stock | $9.39B | $9.14B | $8.89B | $8.64B | $8.64B | $8.64B | $8.41B | $8.35B | $7.74B | $7.65B | · | $7.12B | $7.12B | $7.11B | · | $6.72B | |
| AOCI | $-164M | $-190M | $-206M | $-284M | $-284M | $-287M | $-263M | $-202M | $-195M | $-211M | · | $-186M | $-178M | $-178M | · | $-245M | |
| Stockholders' Equity | $12.62B | $12.67B | $12.70B | $12.76B | $12.53B | $12.40B | $12.47B | $12.37B | $12.74B | $12.60B | · | $12.51B | $12.37B | $12.15B | · | $12.24B | |
| Liabilities + Equity | $22.80B | $22.72B | $23.09B | $23.49B | $22.87B | $22.18B | $21.37B | $21.72B | $21.52B | $21.45B | · | $21.22B | $21.29B | $21.24B | · | $21.33B | |
| Shares Outstanding | 319,400,000 | 319,300,000 | 318,700,000 | 318,700,000 | 318,400,000 | 318,400,000 | 317,500,000 | 317,400,000 | 317,200,000 | 317,200,000 | 316,200,000 | 316,000,000 | 315,800,000 | 315,400,000 | 313,800,000 | 313,600,000 |
Cashflow 13
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $271M | $270M | $284M | $284M | $272M | $254M | $264M | $251M | $243M | $239M | $241M | $241M | $238M | $232M | $228M | $231M | |
| Stock-based Comp | $25M | $24M | $24M | $25M | $21M | $20M | $21M | $24M | $26M | $29M | $25M | $16M | $34M | $25M | $27M | $27M | |
| Amort. of Intangibles | $163M | $162M | $178M | $176M | $161M | $151M | $158M | $148M | $144M | $142M | $145M | $145M | $138M | $133M | $132M | $132M | |
| Other Non-cash | · | $-173M | · | · | · | $-73M | · | · | · | $-212M | · | · | · | $-182M | · | · | |
| Operating Cash Flow | $448M | $359M | $517M | $419M | $378M | $383M | $506M | $396M | $369M | $228M | $588M | $338M | $348M | $308M | $244M | $451M | |
| CapEx | $54M | $36M | $75M | $55M | $50M | $45M | $52M | $44M | $53M | $55M | $63M | $84M | $97M | $47M | $63M | $47M | |
| Investing Cash Flow | $-191M | $-159M | $-322M | $-163M | $-1.38B | $-106M | $-291M | $-155M | $-247M | $-195M | $-221M | $-166M | $-243M | $-149M | · | · | |
| Stock Repurchased | $251M | $250M | $250M | $0 | $7M | $230M | $72M | $596M | $86M | $114M | $410M | $0 | $14M | $268M | · | · | |
| Net Stock Activity | · | $-250M | · | · | · | $-230M | · | · | · | $-114M | · | · | · | $-268M | · | · | |
| Dividends Paid | $46M | $47M | $48M | $48M | $48M | $48M | $48M | $49M | $49M | $49M | $50M | $50M | $50M | $50M | $50M | $50M | |
| Financing Cash Flow | $-271M | $-369M | $-897M | $484M | $164M | $575M | $-241M | $-102M | $-92M | $-50M | $-251M | $-196M | $-109M | $-207M | · | · | |
| Net Change in Cash | $-14M | $-168M | $-701M | $736M | $-828M | $859M | $-44M | $149M | $27M | $-23M | $124M | $-28M | $-10M | $-46M | $-170M | $159M | |
| Free Cash Flow | · | $323M | · | · | · | $338M | · | · | · | $173M | · | · | · | $261M | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 15.0% | 17.9% | · | 17.5% | 14.4% | 15.3% | · | 15.3% | 18.1% | 14.1% | · | 15.2% | 17.6% | 17.9% | · | 14.7% | |
| Net Margin | 9.1% | 11.4% | · | 11.5% | 7.4% | 9.5% | · | 13.7% | 12.5% | 9.1% | · | 9.3% | 11.2% | 12.7% | · | 11.6% | |
| Pretax Margin | 11.7% | 14.4% | · | 14.0% | 10.8% | 12.0% | · | 12.6% | 15.6% | 11.4% | · | 12.5% | 14.8% | 15.7% | · | 10.6% | |
| EBITDA Margin | 15.0% | 30.8% | · | 17.5% | 14.4% | 28.6% | · | 15.3% | 18.1% | 26.7% | · | 15.2% | 17.6% | 30.5% | · | 14.7% | |
| ROA | 0.87% | 1.1% | · | 1.0% | 0.69% | 0.83% | · | 1.2% | 1.1% | 0.81% | · | 0.76% | 0.98% | 1.1% | · | 0.86% | |
| ROE | 1.6% | 1.9% | · | 1.8% | 1.2% | 1.5% | · | 2.0% | 1.9% | 1.4% | · | 1.3% | 1.7% | 1.9% | · | 1.6% | |
| ROIC | 1.3% | 1.5% | · | 1.4% | 1.0% | 1.2% | · | 1.6% | 1.5% | 1.2% | · | 1.1% | 1.4% | 1.5% | · | 1.5% |
Liquidität & Solvenz 4
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.7 | · | 2.4 | 1.9 | 2.4 | · | 1.4 | 1.3 | 1.7 | · | 2.1 | 2.0 | 1.9 | · | 2.0 | |
| Quick Ratio | 0.7 | 0.8 | · | 1.2 | 0.8 | 1.3 | · | 0.6 | 0.5 | 0.7 | · | 0.8 | 0.8 | 0.7 | · | 0.8 | |
| Debt / Equity | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.4 | 0.5 | 0.5 | · | 0.5 | |
| LT Debt / Equity | 0.5 | 0.5 | · | 0.6 | 0.5 | 0.5 | · | 0.4 | 0.3 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 |
Effizienz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.3 | 1.4 | 1.3 | · | 1.3 | 1.4 | 1.3 | · | 1.3 | 1.4 | 1.4 | · | 1.3 |
Bewertung (TTM) 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8.34B | $8.07B | · | $7.81B | $7.75B | $7.56B | · | $7.41B | $7.45B | $7.34B | · | $7.12B | $7.15B | $6.95B | · | $6.80B | |
| Net Income TTM | $820M | $804M | · | $815M | $827M | $846M | · | $827M | $788M | $777M | · | $799M | $790M | $594M | · | $508M | |
| Market Cap | $27.50B | $28.87B | · | $31.39B | $29.04B | $36.04B | · | $34.26B | $34.43B | $41.86B | · | $35.46B | $45.98B | $40.75B | · | $32.79B | |
| Enterprise Value | $34.57B | $35.92B | · | $38.21B | $36.06B | $41.83B | · | $40.15B | $39.84B | $47.27B | · | $40.65B | $51.37B | $46.21B | · | $37.96B | |
| P/E | 20.6 | 22.3 | · | 24.2 | 22.3 | 27.2 | · | 26.9 | 28.6 | 35.5 | · | 29.5 | 38.7 | 45.7 | · | 43.4 | |
| P/S | 3.3 | 3.6 | · | 4.0 | 3.7 | 4.8 | · | 4.6 | 4.6 | 5.7 | · | 5.0 | 6.4 | 5.9 | · | 4.8 | |
| P/B | 2.2 | 2.3 | · | 2.5 | 2.3 | 2.9 | · | 2.8 | 2.7 | 3.3 | · | 2.8 | 3.7 | 3.4 | · | 2.7 | |
| P / Cash Flow | · | 80.3 | · | · | · | 94.1 | · | · | · | 183.6 | · | · | · | 132.4 | · | · | |
| P / FCF | · | 89.4 | · | · | · | 106.6 | · | · | · | 242.1 | · | · | · | 156.1 | · | · | |
| EV / EBITDA | 106.0 | 55.8 | · | 108.8 | 120.2 | 76.5 | · | 143.6 | 113.4 | 93.7 | · | 152.5 | 155.9 | 82.6 | · | 154.7 | |
| EV / FCF | · | 111.2 | · | · | · | 123.7 | · | · | · | 273.4 | · | · | · | 177.0 | · | · | |
| EV / Revenue | 4.1 | 4.4 | · | 4.9 | 4.7 | 5.5 | · | 5.4 | 5.3 | 6.4 | · | 5.7 | 7.2 | 6.7 | · | 5.6 | |
| Earnings Yield | 4.9% | 4.5% | · | 4.1% | 4.5% | 3.7% | · | 3.7% | 3.5% | 2.8% | · | 3.4% | 2.6% | 2.2% | · | 2.3% | |
| Payout Ratio | · | 19.7% | · | · | · | 26.3% | · | · | · | 28.6% | · | · | · | 21.6% | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $8.23B | $7.68B | $7.39B | $6.94B | $6.83B |
| Betriebsgewinnmarge % | 13.3% | 16.7% | 17.3% | 10.0% | 10.0% |
| Nettoergebnis | $705M | $904M | $1.02B | $231M | $402M |
| Verwässerte EPS | $3.55 | $4.43 | $4.88 | $1.10 | $1.91 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.6 | 0.5 | 0.5 | 0.5 | 0.6 |
| Liquiditätsgrad | 2.0 | 1.9 | 1.6 | 1.9 | 1.4 |
| Quick Ratio | 0.9 | 0.8 | 0.7 | 0.7 | 0.5 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $1.47B | $1.30B | $1.29B | $1.17B | $1.33B |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 988 Einreicher · $13.8B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 97 (-11 vs. Vorquartal) | 80 (-21 vs. Vorquartal) | 309 (+10 vs. Vorquartal) | 285 (-9 vs. Vorquartal) | +42.9M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Dodge & Cox | $2.076.898.436 | 24.124.735 | 15,04% | Aktien |
| VANGUARD GROUP INC | $1.933.855.758 | 21.506.403 | 14,01% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.087.741.726 | 12.634.937 | 7,88% | Aktien |
| Capital International Investors | $1.048.887.329 | 12.183.614 | 7,60% | Aktien |
| STATE STREET CORP | $766.342.640 | 8.877.171 | 5,55% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $726.749.999 | 8.441.747 | 5,26% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $404.158.240 | 4.715.128 | 2,93% | Aktien |
| PRIMECAP MANAGEMENT CO/CA/ | $328.577.983 | 3.816.680 | 2,38% | Aktien |
| CITADEL ADVISORS LLC | $291.791.380 | 3.389.376 | 2,11% | Aktien |
| VAN ECK ASSOCIATES CORP | $272.449.712 | 3.164.708 | 1,97% | Aktien |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $237.731.423 | 2.761.429 | 1,72% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $236.270.951 | 2.744.463 | 1,71% | Aktien |
| EQUITY INVESTMENT CORP | $144.748.296 | 1.681.360 | 1,05% | Aktien |
| NORGES BANK | $136.661.935 | 1.587.431 | 0,99% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $134.484.547 | 1.562.139 | 0,97% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $130.516.582 | 1.516.049 | 0,95% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $125.541.517 | 1.458.259 | 0,91% | Aktien |
| Vestal Point Capital, LP | $120.526.000 | 1.400.000 | 0,87% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $118.547.135 | 1.377.014 | 0,86% | Aktien |
| Holocene Advisors, LP | $101.367.617 | 1.177.461 | 0,73% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $99.065.937 | 1.150.725 | 0,72% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $93.508.375 | 1.086.170 | 0,68% | Aktien |
| Camber Capital Management LP | $91.210.000 | 1.000.000 | 0,66% | Aktien |
| AMERIPRISE FINANCIAL INC | $84.139.928 | 977.319 | 0,61% | Aktien |
| TORONTO DOMINION BANK | $81.590.162 | 947.731 | 0,59% | Aktien |
| Woodline Partners LP | $81.122.607 | 942.300 | 0,59% | Aktien |
| Point72 Asset Management, L.P. | $75.746.373 | 879.851 | 0,55% | Aktien |
| Sound Shore Management Inc /CT/ | $68.407.286 | 794.602 | 0,50% | Aktien |
| CAUSEWAY CAPITAL MANAGEMENT LLC | $67.908.650 | 788.810 | 0,49% | Aktien |
| Quantinno Capital Management LP | $62.169.005 | 722.139 | 0,45% | Aktien |
| Meridiem Capital Partners LP | $54.973.200 | 638.555 | 0,40% | Aktien |
| BANK OF AMERICA CORP /DE/ | $53.807.541 | 625.015 | 0,39% | Aktien |
| Nuveen Asset Management, LLC | $52.849.964 | 500.331 | 0,38% | Aktien |
| SHAPIRO CAPITAL MANAGEMENT LLC | $52.119.833 | 605.411 | 0,38% | Aktien |
| Magellan Asset Management Ltd | $49.106.511 | 570.409 | 0,36% | Aktien |
| Swiss National Bank | $47.005.140 | 546.000 | 0,34% | Aktien |
| RHUMBLINE ADVISERS | $42.395.593 | 492.458 | 0,31% | Aktien |
| Mitsubishi UFJ Asset Management Co., Ltd. | $41.500.115 | 482.055 | 0,30% | Aktien |
| BARCLAYS PLC | $41.350.664 | 480.319 | 0,30% | Aktien |
| Douglas Lane & Associates, LLC | $41.132.119 | 477.780 | 0,30% | Aktien |
| BANK OF MONTREAL /CAN/ | $40.852.890 | 474.537 | 0,30% | Aktien |
| Vanguard Global Advisers, LLC | $38.276.991 | 444.616 | 0,28% | Aktien |
| Sumitomo Mitsui Trust Group, Inc. | $38.269.846 | 444.533 | 0,28% | Aktien |
| Legal & General Group Plc | $37.993.324 | 441.321 | 0,28% | Aktien |
| WILSEY ASSET MANAGEMENT INC | $36.318.495 | 421.867 | 0,26% | Aktien |
| BlackRock, Inc. | $36.112.517 | 419.474 | 0,26% | Aktien |
| HARRIS ASSOCIATES L P | $34.583.300 | 401.711 | 0,25% | Aktien |
| FIRST TRUST ADVISORS LP | $34.081.553 | 395.884 | 0,25% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $33.676.170 | 391.174 | 0,24% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $33.194.840 | 385.583 | 0,24% | Aktien |
| CANADA PENSION PLAN INVESTMENT BOARD | $32.542.881 | 378.010 | 0,24% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $31.339.310 | 364.030 | 0,23% | Aktien |
| California Public Employees Retirement System | $30.898.218 | 358.906 | 0,22% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $30.323.251 | 335.360 | 0,22% | Aktien |
| Boston Trust Walden Corp | $28.067.664 | 326.027 | 0,20% | Aktien |
| Defilade Capital Management, L.P. | $27.327.204 | 317.426 | 0,20% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $26.564.879 | 308.571 | 0,19% | Aktien |
| Boston Partners | $26.551.020 | 308.410 | 0,19% | Aktien |
| Alberta Investment Management Corp | $25.645.694 | 297.894 | 0,19% | Aktien |
| Minneapolis Portfolio Management Group, LLC | $25.207.094 | 292.799 | 0,18% | Aktien |
| GOLDMAN SACHS GROUP INC | $25.087.753 | 291.413 | 0,18% | Aktien |
| Parkman Healthcare Partners LLC | $20.020.832 | 232.557 | 0,14% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $19.777.893 | 212.437 | 0,14% | Aktien |
| GAMCO INVESTORS, INC. ET AL | $19.685.167 | 228.658 | 0,14% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $19.434.604 | 214.937 | 0,14% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $19.117.576 | 222.065 | 0,14% | Aktien |
| National Pension Service | $17.169.531 | 199.437 | 0,12% | Aktien |
| MOORE CAPITAL MANAGEMENT, LP | $17.101.090 | 198.642 | 0,12% | Aktien |
| Capital International, Inc./CA/ | $15.768.158 | 183.159 | 0,11% | Aktien |
| ST GERMAIN D J CO INC | $15.673.459 | 182.059 | 0,11% | Aktien |
| ExodusPoint Capital Management, LP | $15.572.304 | 180.884 | 0,11% | Aktien |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $15.414.156 | 179.047 | 0,11% | Aktien |
| Invenomic Capital Management LP | $15.383.508 | 178.691 | 0,11% | Aktien |
| Eurizon Capital SGR S.p.A. | $15.141.875 | 175.862 | 0,11% | Aktien |
| AVIVA PLC | $14.285.947 | 165.942 | 0,10% | Aktien |
| EASTERLY INVESTMENT PARTNERS LLC | $13.890.966 | 161.354 | 0,10% | Aktien |
| M&G PLC | $13.584.818 | 157.963 | 0,10% | Aktien |
| QSM Asset Management Ltd | $13.189.800 | 154.375 | 0,10% | Aktien |
| NATIONAL BANK OF CANADA /FI/ | $13.033.753 | 151.274 | 0,09% | Aktien |
| ARMOR ADVISORS, L.L.C. | $13.022.318 | 151.264 | 0,09% | Aktien |
| Schonfeld Strategic Advisors LLC | $12.725.613 | 603.216 | 0,09% | Aktien |
| MACKENZIE FINANCIAL CORP | $12.604.781 | 146.414 | 0,09% | Aktien |
| Brandywine Global Investment Management, LLC | $12.512.458 | 139.151 | 0,09% | Aktien |
| GABELLI FUNDS LLC | $12.470.137 | 144.850 | 0,09% | Aktien |
| MARSHALL WACE, LLP | $12.440.005 | 144.500 | 0,09% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $12.356.412 | 143.529 | 0,09% | Aktien |
| Northside Capital Management, LLC | $12.266.648 | 135.663 | 0,09% | Aktien |
| SECTOR GAMMA AS | $12.251.210 | 142.307 | 0,09% | Aktien |
| SPEECE THORSON CAPITAL GROUP INC | $11.928.000 | 138.547 | 0,09% | Aktien |
| FRANKLIN RESOURCES INC | $11.460.043 | 133.117 | 0,08% | Aktien |
| Sio Capital Management, LLC | $11.316.100 | 131.445 | 0,08% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $11.052.000 | 128.379 | 0,08% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $10.942.599 | 127.107 | 0,08% | Aktien |
| Bellevue Group AG | $10.908.206 | 126.707 | 0,08% | Aktien |
| KLCM Advisors, Inc. | $10.810.149 | 125.568 | 0,08% | Aktien |
| United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund | $10.566.256 | 122.735 | 0,08% | Aktien |
| State of Tennessee, Department of Treasury | $10.467.770 | 121.591 | 0,08% | Aktien |
| APG Asset Management N.V. | $10.354.444 | 137.510 | 0,07% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $10.320.358 | 114.138 | 0,07% | Aktien |
| Tredje AP-fonden | $10.157.243 | 117.984 | 0,07% | Aktien |
Unternehmensinsider 63 Insider · 36 Führungskräfte · 24 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Ivan Tornos | President & CEO | 6. März 2025 M | 51.753 | 0 | 0 | $0 |
| Bryan C Hanson | President and CEO | 6. März 2023 A | 102.797 | 0 | 0 | $0 |
| John Raymond Elliott | Chairman, Pres. & CEO | 12. Februar 2007 M | 62.751 | 0 | 0 | $0 |
| Suketu Upadhyay | Exec. VP, CFO | 6. März 2025 M | 48.853 | 0 | 0 | $0 |
| Florin Daniel P | Exec. VP, CFO | 8. Mai 2019 G | 25.471 | 0 | 0 | $0 |
| James T Crines | EVP, Finance and CFO | 19. März 2015 M | 56.313 | 0 | 0 | $0 |
| Sang Yi | Group President, Asia Pacific | 29. Mai 2026 S | 27.251 | 0 | 2 | $-413.216 |
| Mark Bezjak | President, Americas | 6. März 2025 M | 13.134 | 0 | 0 | $0 |
| Didier Deltort | President, EMEA | 26. Februar 2021 M | 4.619 | 0 | 0 | $0 |
| Aure Bruneau | Group President | 11. November 2019 M | 757 | 0 | 0 | $0 |
| Robert D. Delp | President, Americas | 20. März 2018 A | — | 0 | 0 | $0 |
| David A. Nolan Jr. | Group President | 20. März 2018 A | 9.102 | 0 | 0 | $0 |
| Daniel E. Williamson | Group President | 20. März 2018 A | 2.000 | 0 | 0 | $0 |
| Adam Rudolph Johnson | Group President | 24. Juni 2017 M | 11.093 | 0 | 0 | $0 |
| Stuart G. Kleopfer | President, Americas | 23. August 2016 S | 3.000 | 0 | 0 | $0 |
| Stephen H L Ooi | President, Asia Pacific | 19. März 2015 M | 45.411 | 0 | 0 | $0 |
| Joseph A. Cucolo | President, Americas | 1. Oktober 2014 M | 11.226 | 0 | 0 | $0 |
| Jon E Kramer | President, U.S. Sales | 12. Dezember 2008 M | 4.461 | 0 | 0 | $0 |
| Kevin R Thornal | Grp Pres-Global Business | 1. August 2026 M | 5.691 | 0 | 0 | $0 |
| Jehanzeb Noor | Senior Vice President, Chief Strategy, Innovation & Business Development Officer | 1. Juni 2026 A | — | 0 | 0 | $0 |
| Wilfred Van Zuilen | Group Pres, EMEA | 1. Juli 2025 M | 21.473 | 0 | 0 | $0 |
| Paul A Stellato | VP, Controller & CAO | 1. Juni 2025 M | 2.772 | 0 | 0 | $0 |
| Lori Winkler | SVP and CHRO | 6. März 2025 M | 9.833 | 0 | 0 | $0 |
| Rachel Ellingson | Chief Administrative Officer | 20. Februar 2025 M | 11.906 | 0 | 0 | $0 |
| Derek M Davis | Interim Controller & CAO | 1. März 2022 A | 6.809 | 0 | 0 | $0 |
| Carrie Ann Nichol | VP, Controller & CAO | 1. Oktober 2021 M | 338 | 0 | 0 | $0 |
| Tony W. Collins | VP, Controller and CAO | 31. Juli 2018 M | 368 | 0 | 0 | $0 |
| Katarzyna Mazur-Hofsaess | Pres., Eur., M. East & Afr. | 22. Mai 2018 M | 16.682 | 0 | 0 | $0 |
| Jeffery A Mccaulley | Pres - Zimmer Reconstructive | 8. Januar 2014 M | 5.211 | 0 | 0 | $0 |
| Jeffrey B Paulsen | Group Pres., Global Businesses | 16. März 2013 M | 6.095 | 0 | 0 | $0 |
| Cheryl R Blanchard | Sr. VP, Chief Scientific Off. | 19. März 2012 A | 18.357 | 0 | 0 | $0 |
| Mark C Throdahl | Group Pres - Global Business | 12. Juni 2009 D | 844 | 0 | 0 | $0 |
| Sheryl L Conley | Group Pres., Americas & Mktg. | 12. Februar 2008 A | 2.559 | 0 | 0 | $0 |
| Sam R Leno | EVP | 4. Mai 2007 D | 27.513 | 0 | 0 | $0 |
| Richard Fritschi | Pres. Zimmer Europe & Austral. | 18. Januar 2005 A | — | 0 | 0 | $0 |
| Bruce Edward Peterson | Chairman, Zimmer Americas | 17. März 2004 M | 17.975 | 0 | 0 | $0 |
| Louis Shapiro | Direktor | 30. Juni 2026 A | — | 0 | 0 | $0 |
| Devdatt Kurdikar | Direktor | 30. Juni 2026 A | — | 0 | 0 | $0 |
| Sreelakshmi Kolli | Direktor | 30. Juni 2026 A | 1.000 | 0 | 0 | $0 |
| Maria Teresa Hilado | Direktor | 30. Juni 2026 A | 1.650 | 0 | 0 | $0 |
| Michael J. Farrell | Direktor | 30. Juni 2026 A | 2.000 | 0 | 0 | $0 |
| Robert Hagemann | Direktor | 30. Juni 2026 A | 4.000 | 0 | 0 | $0 |
| HIGGINS ARTHUR J | Direktor | 30. Juni 2026 A | 3.400 | 0 | 0 | $0 |
| Betsy J Bernard | Direktor | 22. Mai 2026 A | 5.271 | 0 | 0 | $0 |
| Syed A. Jafry | Direktor | 30. Juni 2025 A | 4.060 | 0 | 0 | $0 |
| Christopher B Begley | Direktor | 31. März 2025 A | 3.540 | 0 | 0 | $0 |
| Michael W Michelson | Direktor | 10. Mai 2024 A | 3.385 | 0 | 0 | $0 |
| Gail Boudreaux | Direktor | 31. März 2021 A | 2.095 | 0 | 0 | $0 |
| Larry C Glasscock | Direktor | 8. Mai 2020 A | 10.861 | 0 | 0 | $0 |
| Jeffrey K. Rhodes | Direktor | 31. März 2018 A | — | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 6 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Zimmer Biomet Holdings, Inc., Honey Badger Merger Sub, Inc. | 15. Juli 2025 | 27,00% | Erste Einreichung | M&A / Verkauf | SEC |
| KKR Biomet LLC, KKR 2006 Fund L.P., OPERF Co-Investment LLC, KKR PEI Investments, L.P., 8 North America Investor L.P., KKR Partners III, L.P., KKR Associates 2006 LP, KKR 2006 GP LLC, KKR PEI Associates, L.P., KKR PEI GP Limited, KKR Associates 8 NA L.P., KKR 8 NA Limited, KKR III GP LLC, KKR Fund Holdings L.P., KKR Fund Holdings GP Limited, KKR Group Holdings L.P., KKR Group Limited, KKR & Co. L.P., KKR Management LLC, Henry R. Kravis, George R. Roberts ×3 Einreichungen | 16. Juni 2016 | — | Erste Einreichung | — | SEC |
| TPG Group Holdings (SBS) Advisors, Inc., David Bonderman, James G. Coulter ×3 Einreichungen | 16. Juni 2016 | — | Erste Einreichung | Kapitalstruktur | SEC |
| Blackstone Capital Partners V, L.P., Blackstone Capital Partners V-AC L.P., BCP V-S L.P., Blackstone Family Investment Partnership V L.P., Blackstone Family Investment Partnership V-SMD L.P., Blackstone Participation Partnership V L.P., BCP V Co-Investors L.P., Blackstone Management Associates V L.L.C., BMA V L.L.C., BCP V Side-By-Side GP L.L.C., Blackstone Family GP L.L.C., Blackstone Holdings III L.P., Blackstone Holdings III GP L.P., Blackstone Holdings III GP Management L.L.C., The Blackstone Group L.P., Blackstone Group Management L.L.C., Stephen A. Schwarzman ×3 Einreichungen | 12. Februar 2016 | — | Erste Einreichung | — | SEC |
| LVB Acquisition Holding, LLC ×2 Einreichungen | 9. Februar 2016 | — | Erste Einreichung | — | SEC |
| Zimmer Holdings, Inc., Zimmer, Inc., Zimmer CEP USA Holding Co. ×3 Einreichungen | 10. August 2006 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 166 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IHI · iShares Trust | 2,66% | 916.732 SH | 8. August 2026 | Täglich |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,97% | 209.273 NS | 30. April 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,66% | 134.444 SH | 8. August 2026 | Täglich |
| AGNG · Global X Funds | 1,14% | 11.291 NS | 31. Mai 2026 | N-PORT |
| CVAR · ETF Opportunities Trust | 0,86% | 4.059 NS | 30. April 2026 | N-PORT |
| SOVF · Elevation Series Trust | 0,70% | 8.041 NS | 30. April 2026 | N-PORT |
| FTA · First Trust Exchange-Traded AlphaDE… | 0,64% | 100.144 NS | 30. April 2026 | N-PORT |
| ABCS · EA Series Trust | 0,62% | 857 NS | 29. Mai 2026 | N-PORT |
| UPSD · ETF Series Solutions | 0,45% | 5.488 NS | 30. April 2026 | N-PORT |
| AUSF · Global X Funds | 0,44% | 45.318 NS | 31. Mai 2026 | N-PORT |
| SIXL · EXCHANGE TRADED CONCEPTS TRUST | 0,38% | 8.729 NS | 31. Mai 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 0,36% | 62.758 SH | 8. August 2026 | Täglich |
| COWZ · Pacer Funds Trust | 0,32% | 714.689 NS | 30. April 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 0,32% | 1.835 NS | 30. April 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,31% | 5.282 NS | 30. April 2026 | N-PORT |
| IYH · iShares Trust | 0,31% | 115.801 SH | 8. August 2026 | Täglich |
| ITAN · EA Series Trust | 0,30% | 3.279 NS | 29. Mai 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,30% | 54.347 NS | 30. April 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,26% | 91.433 NS | 30. April 2026 | N-PORT |
| IMCV · iShares Trust | 0,26% | 30.985 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,25% | 581.880 SH | 8. August 2026 | Täglich |
| IXJ · iShares Trust | 0,24% | 101.995 SH | 8. August 2026 | Täglich |
| RXL · ProShares Trust | 0,24% | 2.067 NS | 31. Mai 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0,24% | 3.951 NS | 30. April 2026 | N-PORT |
| DFVE · DoubleLine ETF Trust | 0,21% | 640 NS | 31. März 2026 | N-PORT |
| SIZE · iShares Trust | 0,21% | 9.450 SH | 8. August 2026 | Täglich |
| RSP · Invesco Exchange-Traded Fund Trust | 0,21% | 2.104.987 SH | 8. August 2026 | Täglich |
| EUSA · iShares, Inc. | 0,20% | 39.545 SH | 8. August 2026 | Täglich |
| VLUE · iShares Trust | 0,20% | 190.720 SH | 8. August 2026 | Täglich |
| GSEW · Goldman Sachs ETF Trust | 0,19% | 41.670 NS | 31. Mai 2026 | N-PORT |
| IWS · iShares Trust | 0,18% | 292.628 SH | 8. August 2026 | Täglich |
| VBR · VANGUARD INDEX FUNDS | 0,18% | 1.408.631 SH | 8. August 2026 | Täglich |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,17% | 8.204 NS | 31. Mai 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0,15% | 3.949.000 | 8. August 2026 | Täglich |
| VFVA · VANGUARD WELLINGTON FUND | 0,15% | 15.020 SH | 8. August 2026 | Täglich |
| VOE · VANGUARD INDEX FUNDS | 0,14% | 621.372 SH | 8. August 2026 | Täglich |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,14% | 6.177.000 | 8. August 2026 | Täglich |
| IWR · iShares Trust | 0,13% | 788.276 SH | 8. August 2026 | Täglich |
| IMCB · iShares Trust | 0,13% | 22.265 SH | 8. August 2026 | Täglich |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,12% | 150.000 | 8. August 2026 | Täglich |
| GINN · Goldman Sachs ETF Trust | 0,12% | 3.104 NS | 31. Mai 2026 | N-PORT |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,12% | 4.159.000 | 8. August 2026 | Täglich |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,12% | 10.471 NS | 30. April 2026 | N-PORT |
| XOEF · iShares Trust | 0,11% | 248 SH | 8. August 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,10% | 2.218.373 SH | 8. August 2026 | Täglich |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 8.531 SH | 8. August 2026 | Täglich |
| CSM · ProShares Trust | 0,10% | 6.106 NS | 31. Mai 2026 | N-PORT |
| USNZ · DBX ETF Trust | 0,09% | 3.290 NS | 29. Mai 2026 | N-PORT |
| CAPE · DoubleLine ETF Trust | 0,08% | 2.439 NS | 31. März 2026 | N-PORT |
| GSLC · Goldman Sachs ETF Trust | 0,08% | 155.905 NS | 31. Mai 2026 | N-PORT |